Researchers tested different antibiotics on mice that resulted in microbiota changes and various susceptibility to C. difficile.
They found Clostridium scindens, a microbe that is part of the gut’s natural flora,was linked to resistance to C. difficile infections. Additionally, when administering Clostridium scindens, resistance to infection was enhanced, according to the study.
Researchers suggest Clostridium scindens is a strong probiotic candidate for restoring the gut microbiome in the event of a C. difficle infection and that their findings have implications for designing antimicrobials and therapeutics for patients at risk of developing such infections.
More articles on HAIs:
Preventing SSIs: The sterile processing connection
Mission Hospital resumes elective surgeries after infection issue
How much does an inpatient C. diff infection cost?
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
